malondialdehyde has been researched along with Phobic Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atmaca, M; Kuloglu, M; Tezcan, E; Tunckol, H; Ustundag, B | 1 |
Atmaca, M; Kuloglu, M; Tezcan, E; Ustundag, B | 1 |
1 trial(s) available for malondialdehyde and Phobic Disorders
Article | Year |
---|---|
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment.
Topics: Antidepressive Agents, Second-Generation; Catalase; Citalopram; Glutathione Peroxidase; Humans; Malondialdehyde; Oxidoreductases; Phobic Disorders; Superoxide Dismutase | 2004 |
1 other study(ies) available for malondialdehyde and Phobic Disorders
Article | Year |
---|---|
Antioxidant enzyme and malondialdehyde levels in patients with social phobia.
Topics: Adolescent; Adult; Antioxidants; Catalase; Control Groups; Diagnostic and Statistical Manual of Mental Disorders; Female; Free Radicals; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Phobic Disorders; Psychiatric Status Rating Scales; Superoxide Dismutase | 2008 |